Publications by authors named "Heike Michael"

Claim this Profile
H
Health-related quality of life in patients with aggressive non-Hodgkin lymphoma: results from the PETAL trial.
Ulrich Dührsen, Gabriele Prange-Krex, Regina Moeller, Harald Held, Gerhard Heil, Michael Heike, Michael Nonnemacher

Ann Hematol· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Baseline and interim PET-based outcome prediction in peripheral T-cell lymphoma: A subgroup analysis of the PETAL trial.
Christine Schmitz, Jan Rekowski, Stefan P Müller, Bernd Hertenstein, Christiane Franzius, Michael Heike

Hematol Oncol· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Perioperative chemotherapy with fluorouracil plus leucovorin, oxaliplatin, and docetaxel versus fluorouracil or capecitabine plus cisplatin and epirubicin for locally advanced, resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4): a randomised, phase 2/3 trial.
Salah-Eddin Al-Batran, Nils Homann, Claudia Pauligk, Thorsten O Goetze, Johannes Meiler, Michael Pohl, Michael Koenigsmann, Michael Schenk, Michael Heike, Michael Kneba

Lancet· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dermatux: phase IV trial of Cetuximab plus FOLFIRI in first-line metastatic colorectal cancer receiving a pre-defined skin care.
Carl Christoph Schimanski, Frank Staib, Thomas Göhler, Holger Hebart, Michael Heike, Michael Neise

J Cancer Res Clin Oncol· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Histopathological regression after neoadjuvant docetaxel, oxaliplatin, fluorouracil, and leucovorin versus epirubicin, cisplatin, and fluorouracil or capecitabine in patients with resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4-AIO): results from the phase 2 part of a multicentre, open-label, randomised phase 2/3 trial.
Salah-Eddin Al-Batran, Ralf D Hofheinz, Claudia Pauligk, Hans-Georg Kopp, Georg Martin Haag, Michael Koenigsmann, Michael Clemens, Michael Pohl, Michael Heike

Lancet Oncol· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Indication for 'Over the scope' (OTS)-clip vs. covered self-expanding metal stent (cSEMS) is unequal in upper gastrointestinal leakage: results from a retrospective head-to-head comparison.
Harald Farnik, Marlene Driller, Thomas Kratt, Carsten Schmidt, Martin Fähndrich, Michael Heike

PLoS One· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Endoscopic full-thickness resection based on the novel Dortmund technique.
Martin Faehndrich, Michael Heike, Marcel Sandmann

Endoscopy· July 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Dortmund endoscopic full-thickness resection method: combination of the over-the-scope clip system and the Inoue cap.
Martin Fähndrich, Michael Heike, Marcel Sandmann

Endoscopy· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Epigenetic modulation of the drug resistance genes MGMT, ABCB1 and ABCG2 in glioblastoma multiforme.
Moritz C Oberstadt, Sandra Bien-Möller, Kerstin Weitmann, Susann Herzog, Katharina Hentschel, Heike Michael

BMC Cancer· December 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
LICC: L-BLP25 in patients with colorectal carcinoma after curative resection of hepatic metastases: a randomized, placebo-controlled, multicenter, multinational, double-blinded phase II trial.
Carl Christoph Schimanski, Markus Möhler, Michael Schön, Eric van Cutsem, Richard Greil, Michael Heike

BMC Cancer· April 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Parvovirus H-1-induced tumor cell death enhances human immune response in vitro via increased phagocytosis, maturation, and cross-presentation by dendritic cells.
Markus H Moehler, Maja Zeidler, Vanessa Wilsberg, Jan J Cornelis, Thomas Woelfel, Michael Heike

Hum Gene Ther· August 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Irinotecan plus folinic acid/continuous 5-fluorouracil as simplified bimonthly FOLFIRI regimen for first-line therapy of metastatic colorectal cancer.
Andreas Teufel, Silke Steinmann, Jürgen Siebler, Christiane Zanke, Herbert Hohl, Michael Heike

BMC Cancer· July 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cross-presentation of human melanoma peptide antigen MART-1 to CTLs from in vitro reconstituted gp96/MART-1 complexes.
Frank Staib, Martin Distler, Karen Bethke, Ute Schmitt, Peter R Galle, Michael Heike

Cancer Immun· April 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Melanoma-reactive class I-restricted cytotoxic T cell clones are stimulated by dendritic cells loaded with synthetic peptides, but fail to respond to dendritic cells pulsed with melanoma-derived heat shock proteins in vitro.
Kristina Fleischer, Burkhard Schmidt, Wolfgang Kastenmüller, Dirk H Busch, Ingo Drexler, Michael Heike

J Immunol· January 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Weekly treatment with irinotecan, folinic acid and infusional 5-fluorouracil (ILF) in patients with advanced gastric cancer.
Markus Moehler, Ulrike Haas, Juergen Siebler, Christoph Schimanski, Christian Hertkorn, Michael Heike

Anticancer Drugs· September 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oncolytic parvovirus H1 induces release of heat-shock protein HSP72 in susceptible human tumor cells but may not affect primary immune cells.
Markus Moehler, Maja Zeidler, Joerg Schede, Jean Rommelaere, Peter R Galle, Michael Heike

Cancer Gene Ther· June 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and efficacy of outpatient treatment with CPT-11 plus bolus folinic acid/5-fluorouracil as first-line chemotherapy for metastatic colorectal cancer.
Markus Moehler, Tanja Hoffmann, Christine Zanke, Horst Hohl, Helmut Burg, Michael Baldus, Michael Heike

Anticancer Drugs· January 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Different efficiency of heat shock proteins (HSP) to activate human monocytes and dendritic cells: superiority of HSP60.
Karen Bethke, Frank Staib, Martin Distler, Ute Schmitt, Helmut Jonuleit, Michael Heike

J Immunol· December 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis